Sign up for our free newsletter — RSVP, STAT — for events, news, and promotions from STAT and our partners delivered straight to your inbox each month.
Interested in featuring your event? Contact us.
January 2021
05jan12:00 pmConnecting startups to the regional supply chainVirtual Hosted by: UMass M2D2
Hosted by
UMass M2D2
Event Details
Are you a startup with a physical product or component? Are you looking for assistance in navigating manufacturing, supply chain, and the path to scaling your idea? Are you curious
Event Details
Are you a startup with a physical product or component? Are you looking for assistance in navigating manufacturing, supply chain, and the path to scaling your idea? Are you curious about how to access free curated connections with suppliers, office hours, webinars, and more?
Please join us on January 5th at 12pm for Connecting Startups to the Regional Supply Chain – a session designed to help startups like you learn about FORGE as a nonprofit resource, the importance of manufacturing locally, and how FORGE can help you scale!
This interactive session is open to any and all startups with physical products or components, and will be led by Anya Losik, Program Manager at FORGE.
Time
Jan. 5, 12-1 p.m.
Location
Virtual
05jan1:00 pmA (continued) conversation on the Covid-19 vaccine rolloutVirtual Hosted by: STAT
Hosted by
STAT
Event Details
As the the distribution of the Covid-19 vaccine kicks into gear, there’s much to discuss. Join STAT’s Helen Branswell and Nancy Messonnier, M.D., director, National Center for Immunization and Respiratory
Event Details
As the the distribution of the Covid-19 vaccine kicks into gear, there’s much to discuss. Join STAT’s Helen Branswell and Nancy Messonnier, M.D., director, National Center for Immunization and Respiratory Diseases (NCIRD) and senior official for the COVID-19 Vaccine Task Force, Centers for Disease Control and Prevention (CDC), for a conversation on what to expect
Time
Jan. 5, 1-2 p.m.
Location
Virtual
Hosted by
Consortium on Law and Values in Health, Environment & the Life Sciences, University of MinnesotaMatt Tveter at tvet0004@umn.edu
Event Details
The Covid-19 pandemic poses profound ethical, legal, and social challenges to researchers, clinicians, public health authorities, legal professionals, and communities. This webinar will focus on challenges in Covid-19 vaccine allocation
Event Details
The Covid-19 pandemic poses profound ethical, legal, and social challenges to researchers, clinicians, public health authorities, legal professionals, and communities. This webinar will focus on challenges in Covid-19 vaccine allocation and distribution. Expert panelists will address how to identify priority groups for vaccine allocation, advance population health and equity, meet the real-world challenges of vaccine distribution, and address vaccine hesitancy.
Panelists will respond to audience questions and will analyze the criteria used when setting priorities for vaccine allocation, issues likely to arise in national and global deployment, and how to address those issues effectively.
Panelists are:
Helene D. Gayle, MD, MPH
President & CEO
The Chicago Community Trust
Bio: Helene D. Gayle has been president and CEO of The Chicago Community Trust, one of the nation’s oldest and largest community foundations, since October 2017. An expert on global development, humanitarian and health issues, Dr. Gayle spent 20 years with the Centers for Disease Control, working primarily on HIV/AIDS. She worked at the Bill & Melinda Gates Foundation, directing programs on HIV/AIDS and other global health issues. She also launched the McKinsey Social Initiative (now McKinsey.org), a nonprofit that builds partnerships for social impact. Dr. Gayle co-chaired the National Academies of Sciences, Engineering, and Medicine working group that produced the Framework for Equitable Allocation of Vaccine for the Novel Coronavirus.
Kristen Ehresmann, RN, MPH
Director, Infectious Disease Epidemiology, Prevention and Control Division
Minnesota Department of Health
Bio: Kristen Ehresmann is an epidemiologist and director of the Infectious Disease Epidemiology, Prevention and Control Division at the Minnesota Department of Health. Ms. Ehresmann has led numerous outbreak investigations, published in peer review journals, and been an invited speaker at national meetings. She currently oversees the epidemiologic response for Covid-19.
Helen Branswell
Senior Writer, Infectious Disease
STAT
Bio: Helen Branswell is STAT’s infectious diseases and global health reporter. She came to STAT in 2015 with 15 years of experience covering health, with a focus on infectious diseases. Ms. Branswell was introduced to epidemic reporting during Toronto’s SARS outbreak in 2003; in the years since she has written about bird flu, the H1N1 flu pandemic, Ebola, Zika, and now leads STAT’s coverage of the coronavirus pandemic. She spent the summer of 2004 embedded at the U.S. Centers for Disease Control and Prevention as a CDC Knight Fellow. In 2010-11 she was a Nieman Global Health Fellow at Harvard, where she focused on polio eradication.
Moderated by:
Michael T. Osterholm, PhD, MPH
Director, Center for Infectious Disease Research and Policy (CIDRAP)
University of Minnesota
Bio: Michael T. Osterholm, PhD, MPH, is Regents Professor, McKnight Presidential Endowed Chair in Public Health, and Director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota. He is a global authority on infectious disease and public health and member of the National Academy of Medicine. From June 2018 through May 2019, he served as Science Envoy for Health Security for the U.S. Department of State.
Susan M. Wolf, JD
Chair, Consortium on Law and Values in Health, Environment & the Life Sciences
McKnight Presidential Professor of Law, Medicine & Public Policy
Faegre Baker Daniels Professor of Law
Professor of Medicine
University of Minnesota
Bio: Susan M. Wolf, JD, is McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre Baker Daniels Professor of Law; and Professor of Medicine at the University of Minnesota. Prof. Wolf is Chair of the University’s Consortium on Law and Values in Health, Environment & the Life Sciences. She is an elected member of the National Academy of Medicine (NAM) and a Fellow of the American Association for the Advancement of Science (AAAS).
Time
Jan. 8, 12-1:30 p.m.
Location
Virtual
08jan6:27 pmPreventing a black market for Covid-19 vaccinesVirtual Hosted by: STAT
Hosted by
STAT
Event Details
Some experts say that it is inevitable that the rich and powerful will find ways to jump the line for the Covid-19 vaccines. That could include lobbying officials, pressuring doctors,
Event Details
Some experts say that it is inevitable that the rich and powerful will find ways to jump the line for the Covid-19 vaccines. That could include lobbying officials, pressuring doctors, or even offering bribes for this precious — and limited — commodity. What can be done to prevent this?
STAT investigative reporter Olivia Goldhill and Nicholas St. Fleur, a Knight-Wallace reporting fellow, will convene a panel of experts to discuss how to make sure the shots get to where they need to go.
- Alison Bateman-House, Ph.D., MPH, MA, assistant professor, Division of Medical Ethics, Department of Population Health, Grossman School of Medicine, NYU Langone Health
- Nikos Passas, Ph.D., professor, School of Criminology and Criminal Justice, Northeastern University
- Olivia Goldhill, investigative reporter, STAT (moderator)
- Nicholas St. Fleur, Knight-Wallace Reporting fellow, STAT (moderator)
- Alok Tayi, Ph.D., vice president of life sciences, Egnyte (sponsor speaker)
Time
Jan. 8, 6:27-6:27 p.m.
Location
Virtual
12jan1:00 pmThe health tech news to watch at CES 2021Virtual Hosted by: STAT
Hosted by
STAT
Event Details
Join STAT’s health tech correspondents Erin Brown and Casey Ross for a discussion on the key news to come out of this influential tech event.
Time
Jan. 12, 1-2 p.m.
Location
Virtual
Hosted by
Cambridge Healthtech Institute
Event Details
While a lot has changed since PepTalk was launched in 2001, CHI's number one goal has always been the same: to serve and unite the biotherapeutics community.
Event Details
While a lot has changed since PepTalk was launched in 2001, CHI’s number one goal has always been the same: to serve and unite the biotherapeutics community.
PepTalk has served as an annual gathering place for key players in the industry, connecting countless people around the world, fostering knowledge sharing, and accelerating biotherapeutics development.
As CHI celebrates their 20th year, they are excited to offer a fully integrated virtual event that will continue to serve as a content hub for the latest research and developments, provide a 1:1 networking platform, offer an interactive exhibit hall, live Q&A sessions, breakout groups, research posters, and so much more.
Join your peers and colleagues from around the world to share insights, case studies, cutting-edge research, and form collaborations to advance biotherapeutics development.
Time
Jan. 19 to Jan. 21 PST
Location
Virtual
19jan1:00 pmWhat to watch in a Biden White House and a new CongressVirtual Hosted by: STAT
Hosted by
STAT
Event Details
STAT’s Washington team, Nicholas Florko, Lev Facher, and Erin Mershon, come together to discuss what policies to watch out for in a Biden White House and a new Congress, now with
Time
Jan. 19, 1-2 p.m.
Location
Virtual
26jan(jan 26)8:00 am28(jan 28)5:00 pmPARP & DDR Inhibitors Summit 2021Virtual Hosted by: Hanson Wade
Hosted by
Hanson WadeKaltrina Kastrati at kaltrina.kastrati@hansonwade.com
Event Details
Returning this year in a digital capacity, as the most comprehensive and definitive event in the field, the 4th Annual PARP & DDR Inhibitors Summit is proud to showcase the
Event Details
Returning this year in a digital capacity, as the most comprehensive and definitive event in the field, the 4th Annual PARP & DDR Inhibitors Summit is proud to showcase the very latest case studies and unique perspectives from 20+ pioneering experts. This year is dedicated to the novel targeting of DNA Damage Response (DDR) pathways, optimizing the use of synthetic lethality, to develop safe and efficacious blockbuster therapies in multiple cancers.
Time
Jan. 26 to Jan. 28
Location
Virtual
Hosted by
Hanson WadeKaltrina Kastrati at kaltrina.kastrati@hansonwade.com
Event Details
R&D & Clinical Processes for the Future: Accurate, Efficient & Cost-Effective The AI-ML: Drug Discovery and Development Summit is the industry’s definitive guide to translating the wealth of tech available to
Event Details
R&D & Clinical Processes for the Future: Accurate, Efficient & Cost-Effective
The AI-ML: Drug Discovery and Development Summit is the industry’s definitive guide to translating the wealth of tech available to successfully implement a working and practically effective drug discovery and development platform.
Designed with leading AI experts from R&D and clinical departments across big pharma, biotech, and academia, this year’s forum features 3 days of real-world case studies and interactive discussions. As such, the 2020 AI-ML Summit will provide you with a roadmap to augmented R&D and clinical decision making with reduced failure rates, increased speed, and improved margins.
This is a critical time for drug developers to make more data-driven decisions, and at the 4th AI-ML: Drug Discovery and Development Summit you will learn how to strategically leverage AI technology to transform your pipelines, and patient’s lives.
Join 80+ like-minded peers who are overhauling outdated R&D and clinical processes to reflect on both successes and failures, and importantly the lessons learned along the way from the last year of implementation and utilization.
Time
Jan. 26 to Jan. 28
Location
Virtual
Hosted by
Hanson WadeKaltrina Kastrati at kaltrina.kastrati@hansonwade.com
Event Details
4th Antigen Specific Immune Tolerance Digital Summit (ASIT) brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation to tackle the complexities behind autoimmune disorders head on.
Event Details
4th Antigen Specific Immune Tolerance Digital Summit (ASIT) brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation to tackle the complexities behind autoimmune disorders head on. With momentum building for antigen specific immunotherapies, ASIT 2021 will be the only antigen-specific summit offering thought-leading content to drive the field towards a more precise and ethical antigen-specific approach to drug development.
Time
Jan. 26 to Jan. 28
Location
Virtual
Hosted by
Harvard Medical School Online Webinar
Event Details
The Covid-19 pandemic poses a challenge for machine learning (ML) algorithms trained on pre-Covid data. Clinical presentations, disease trajectories, radiographic interpretations and recommended medications for Covid all represent a significant
Event Details
The Covid-19 pandemic poses a challenge for machine learning (ML) algorithms trained on pre-Covid data. Clinical presentations, disease trajectories, radiographic interpretations and recommended medications for Covid all represent a significant departure from previous real-world practice patterns and may decrease the performance of established ML algorithms.
In this Harvard Medical School Executive Education webinar, Zak Kohane, MD, PhD, will discuss this Covid discontinuity in the context of a longstanding issue in the field of AI and machine learning: how can algorithms (and the human physicians interacting with them) adapt to shifts in medical knowledge, whether from a novel therapy or a newly described disease? He will outline potential opportunities for AI researchers, and steps that AI experts and clinicians should take to optimize system performance and patient care.
Time
Jan. 26, 12-12:45 p.m.
Location
Virtual
Hosted by
MIT Club of Northern California
Event Details
IT'S TIME TO BUILD. Learn from founders, technologists, investors, and industry leaders from MIT and beyond, working to build the future of healthcare & medicine, from AI-powered diagnostics to innovative business
Event Details
IT’S TIME TO BUILD.
Learn from founders, technologists, investors, and industry leaders from MIT and beyond, working to build the future of healthcare & medicine, from AI-powered diagnostics to innovative business models to COVID, psychedelics, Alzheimer’s, and more.
Choose from 7 live panels with world-renowned experts from a16z, NEA, the WHO, Genentech, and many more, starting with a special fireside chat with MIT Professor and Moderna co-founder Robert S. Langer. Connect with other attendees during curated breakouts and 1-1 networking speed dating. Meet top startups pushing the frontiers of healthcare and medicine.
Time
Jan. 27, 1:30-7:30 p.m.
Location
Virtual
28jan1:00 pmPreventing a black market for Covid-19 vaccinesVirtual Hosted by: STAT
Hosted by
STAT
Event Details
Some experts say that it is inevitable that the rich and powerful will find ways to jump the line for the Covid-19 vaccines. That could include lobbying officials, pressuring
Event Details
- Alison Bateman-House, Ph.D., MPH, MA, assistant professor, Division of Medical Ethics, Department of Population Health, Grossman School of Medicine, NYU Langone Health
- Nikos Passas, Ph.D., professor, School of Criminology and Criminal Justice, Northeastern University
- Olivia Goldhill, investigative reporter, STAT (moderator)
- Nicholas St. Fleur, Knight-Wallace Reporting fellow, STAT (moderator)
- Alok Tayi, Ph.D., vice president of life sciences, Egnyte (sponsor speaker)
Time
Jan. 28, 1-2 p.m.
Location
Virtual